64
Views
0
CrossRef citations to date
0
Altmetric
Review

Adjuncts to transcatheter aortic valve implantation

, , , &
Pages 357-365 | Received 18 Nov 2016, Accepted 16 Feb 2017, Published online: 08 Mar 2017

References

  • Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–1607. ​​​ ​​​
  • Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–2198. ​​​
  • Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609–1620.
  • d'Arcy JL, Coffey S, Loudon MA, et al. Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE population cohort study. Eur Heart J. 2016;ehw229. DOI:10.1093/eurheartj/ehw229. ​​​
  • Généreux P, Demers P, Poulin F. Same day discharge after transcatheter aortic valve replacement: are we there yet? Catheter Cardiovasc Interv. 2015;87:980–982.
  • Eide LSP, Ranhoff AH, Fridlund B, et al. Comparison of frequency, risk factors, and time course of postoperative delirium in octogenarians after transcatheter aortic valve implantation versus surgical aortic valve replacement. Am J Cardiol. 2015;115:802–809.
  • Mayr NP, Michel J, Bleiziffer S, et al. Sedation or general anesthesia for transcatheter aortic valve implantation (TAVI). J Thorac Dis. 2015;7:1518–1526.
  • Tchetche D, Farah B, Misuraca L, et al. Cerebrovascular events post-transcatheter aortic valve replacement in a large cohort of patients: a FRANCE-2 registry substudy. JACC Cardiovasc Interv. 2014;7:1138–1145.
  • Nombela-Franco L, Webb JG, De Jaegere PP, et al. Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation. Circulation. 2012;126:3041–3053.
  • Duncan A, Ludman P, Banya W, et al. Long-term outcomes after transcatheter aortic valve replacement in high-risk patients with severe aortic stenosis: the U.K. transcatheter aortic valve implantation registry. JACC Cardiovasc Interv. 2015;8:645–653.
  • Eggebrecht H, Schmermund A, Voigtländer T, et al. Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention. 2012;8:129–138.
  • Werner N, Zeymer U, Schneider S, et al. Incidence and clinical impact of stroke complicating transcatheter aortic valve implantation: results from the German TAVI registry. Catheter Cardiovasc Interv. 2016;88:644–653. DOI:10.1002/ccd.26612
  • Stortecky S, Windecker S, Pilgrim T, et al. Cerebrovascular accidents complicating transcatheter aortic valve implantation: frequency, timing and impact on outcomes. EuroIntervention. 2012;8:62–70.
  • Athappan G, Gajulapalli RD, Tuzcu ME, et al. A systematic review on the safety of second-generation transcatheter aortic valves. EuroIntervention. 2016;11:1034–1043.
  • Uddin A, Fairbairn TA, Djoukhader IK, et al. Consequence of cerebral embolism after transcatheter aortic valve implantation compared with contemporary surgical aortic valve replacement: effect on health-related quality of life. Circ Cardiovasc Interv. 2015;8:e001913–e001913.
  • Fanning JP, Wesley AJ, Platts DG, et al. The silent and apparent neurological injury in transcatheter aortic valve implantation study (SANITY): concept, design and rationale. BMC Cardiovasc Disord. 2014;14:45.
  • Kahlert P, Knipp SC, Schlamann M, et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation. 2010;121:870–878.
  • Haussig S, Mangner N, Dwyer MG, et al. Effect of a cerebral protection device on brain lesions following transcatheter aortic valve implantation in patients with severe aortic stenosis: the CLEAN-TAVI randomized clinical trial. Jama. 2016;316:592–601.
  • Kapadia SR, Leon MB, Makkar RR, et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet (London, England). 2015;385:2485–2491.
  • Holmes DR Jr, Brennan JM, Rumsfeld JS, et al. Clinical outcomes at 1 year following transcatheter aortic valve replacement. Jama. 2015;313:1019–1028.
  • Deeb GM, Reardon MJ, Chetcuti S, et al. 3-year outcomes in high-risk patients who underwent surgical or transcatheter aortic valve replacement. J Am Coll Cardiol. 2016;67:2565–2574.
  • Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370:1790–1798.
  • Popma JJ, Adams DH, Reardon MJ, et al. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol. 2014;63:1972–1981.
  • Gilard M, Eltchaninoff H, Donzeau-Gouge P, et al. Late outcomes of transcatheter aortic valve replacement in high-risk patients: the FRANCE-2 registry. J Am Coll Cardiol. 2016;68:1637–1647.
  • Di Mario C, Eltchaninoff H, Moat N, et al. The 2011-12 pilot european sentinel registry of transcatheter aortic valve implantation: in-hospital results in 4,571 patients. EuroIntervention. 2013;8:1362–1371.
  • Giustino G, Sorrentino S, Mehran R, et al. Cerebral embolic protection during TAVR: A clinical event meta-analysis. J Am Coll Cardiol. 2017;69:465–466.
  • Van Mieghem NM, Van Gils L, Ahmad H, et al. Filter-based cerebral embolic protection with transcatheter aortic valve implantation: the randomised MISTRAL-C trial. EuroIntervention. 2016;12:499–507.
  • Lansky AJ. A prospective randomized evaluation of the TriGuard™ HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial. Eur Heart J. 2015;36:2070–2078.
  • Alassar A, Soppa G, Edsell M, et al. Incidence and mechanisms of cerebral ischemia after transcatheter aortic valve implantation compared with surgical aortic valve replacement. Ann Thorac Surg. 2015;99:802–808.
  • Ferro CJ, Chue CD, De Belder MA, et al. Impact of renal function on survival after transcatheter aortic valve implantation (TAVI): an analysis of the UK TAVI registry. Heart. 2015;101:546–552.
  • Barbanti M, Gulino S, Capranzano P, et al. Acute kidney injury with the renalguard system in patients undergoing transcatheter aortic valve replacement: the PROTECT-TAVI trial (PROphylactic effecT of furosEmide-induced diuresis with matched isotonic intravenous hydration in transcatheter aortic valve implantation). JACC Cardiovasc Interv. 2015;8:1595–1604. ​​​
  • Rihal CS, Kashani KB. Prevention of acute kidney injury with the renalguard system in patients undergoing transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2015;8:1605–1607.
  • Visconti G, Focaccio A, Donahue M, et al. RenalGuard System for the prevention of acute kidney injury in patients undergoing transcatheter aortic valve implantation. EuroIntervention. 2016;11:e1658–e1661.
  • Unbehaun A, Pasic M, Dreysse S, et al. Transapical aortic valve implantation: incidence and predictors of paravalvular leakage and transvalvular regurgitation in a series of 358 patients. J Am Coll Cardiol. 2012;59:211–221.
  • De Jaegere P, De Santis G, Rodriguez-Olivares R, et al. Patient-specific computer modeling to predict aortic regurgitation after transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2016;9:508–512.
  • Schultz C, Rodriguez-Olivares R, Bosmans J, et al. Patient-specific image-based computer simulation for theprediction of valve morphology and calcium displacement after TAVI with the Medtronic CoreValve and the Edwards SAPIEN valve. EuroIntervention. 2016;11:1044–1052.
  • Piazza N, Onuma Y, Jesserun E, et al. Early and Persistent Intraventricular Conduction Abnormalities and Requirements for Pacemaking After Percutaneous Replacement of the Aortic Valve. JACC Cardiovasc Interv. 2008;1:310–316.
  • Piazza N, Lauzier P, Mylotte D. Transcatheter aortic valve replacement and new conduction abnormalities/permanent pacemaker: can we achieve the intended implant depth? JACC Cardiovasc Interv. 2016;9:255–258.
  • Hell M, Marwan M, Gaede L, et al. Software innovations in computed tomography for structural heart disease interventions. EuroIntervention. 2016;12:X68-X74.
  • Buellesfeld L, Stortecky S, Kalesan B, et al. Aortic root dimensions among patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2013;6:72–83.
  • Fujita B, Kütting M, Seiffert M, et al. Calcium distribution patterns of the aortic valve as a risk factor for the need of permanent pacemaker implantation after transcatheter aortic valve implantation. Eur Heart J Cardiovasc Imaging. 2016;jev343. DOI:10.1093/ehjci/jev343. ​​​
  • Watanabe Y, Lefèvre T, Bouvier E, et al. Prognostic value of aortic root calcification volume on clinical outcomes after transcatheter balloon-expandable aortic valve implantation. Catheter Cardiovasc Interv. 2015;86:1105–1113.
  • Bom N, Lancée CT, Honkoop J, et al. Ultrasonic viewer for cross-sectional analyses of moving cardiac structures. Biomed Eng. 1971;6:3–500, 5.
  • Feigenbaum H. Evolution of echocardiography. Circulation. 1996;93:1321–1327.
  • Smith LA, Monaghan MJ. Monitoring of procedures: peri-interventional echo assessment for transcatheter aortic valve implantation. Eur Heart J Cardiovasc Imaging. 2013;14:840–850.
  • Housden RJ, Ma Y, Arujuna A, et al. Extended-field-of-view three-dimensional transesophageal echocardiography using image-based X-ray probe tracking. Ultrasound Med Biol. 2013;39:993–1005.
  • Balzer J, Zeus T, Hellhammer K, et al. Initial clinical experience using the EchoNavigator(®)-system during structural heart disease interventions. World J Cardiol. 2015;7:562–570. ​​​
  • Eskandari M, Aldalati O, Byrne J, et al. Zero contrast transfemoral transcatheter aortic valve replacement using fluoroscopy-echocardiography fusion imaging. Am J Cardiol. 2016;117:1861–1862.
  • Klettas D, Alcock E, Dworakowski R, et al. Is transnasal TEE imaging a viable alternative to conventional TEE during structural cardiac interventions to avoid general anaesthesia? A pilot comparison study of image quality. Echo Res Pract March 1, 2017. ERP-16-0029. ​​​
  • Bartel T, Edris A, Velik-Salchner C, et al. Intracardiac echocardiography for guidance of transcatheter aortic valve implantation under monitored sedation: a solution to a dilemma? Eur Heart J Cardiovasc Imaging. 2016;17:1–8.
  • Codner P, Lavi I, Malki G, et al. C-THV measures of self-expandable valve positioning and correlation with implant outcomes. Catheter Cardiovasc Interv. 2014;84:877–884.
  • Grapsa J, Kunadian V, Capodanno D, et al. Joint EACVI HIT/EAPCI young survey/ESC CoT survey: training and education for ‘multimodality imaging in structural interventions’: the rise of a new sub-specialty? Eur Heart J Cardiovasc Imaging. 2016;17:1432–1433.
  • Giannopoulos AA, Mitsouras D, Yoo S-J, et al. Applications of 3D printing in cardiovascular diseases. Nat Rev Cardiol. 2016;13:701–718.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.